Abilify

Basic Abilify information

• INN (international nonproprietary name): Aripiprazole
• Brand names available in the United Kingdom: Abilify, Abilify Maintena, Abilify Asimtufii; generic aripiprazole
• ATC code: N05AX12
• Forms and dosages: Tablets 5 mg, 10 mg, 15 mg, 30 mg; orodispersible tablets 10 mg, 15 mg; oral solution 1 mg/mL; long-acting injections (Maintena, Asimtufii)
• Manufacturers in the United Kingdom: Otsuka Pharmaceutical (originator), Lundbeck (co-marketing for Maintena); generic manufacturers such as Sandoz, Teva, Mylan and Zentiva
• Registration status in the United Kingdom: Prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

Abilify is taken once daily, and a consistent routine helps maintain therapeutic levels of the medication. Key points to consider:

• Taking your dose at the same time daily helps form a habit.
• Many people prefer a morning dose, as Abilify can cause restlessness or insomnia in some patients.
• Avoiding late doses can lessen sleep disruption.

For those adjusting to Abilify's effects, monitoring how different dosing times affect sleep is useful.

Taking with or without meals (UK diet habits)

Abilify can be taken with or without food. Food does not significantly affect how well it is absorbed, and there are no strict dietary restrictions. Consistency in how you take it, either always with food or always without, can make the response more predictable. Always consult healthcare professionals before making adjustments to your dosing routine.

Who should avoid it

Abilify needs particular caution in specific patient groups:

• Cardiovascular issues: Those with significant cardiovascular disease, such as a history of heart arrhythmias, may find that the risks outweigh the benefits due to potential QT prolongation.
• Seizure history: Patients with a history of seizures should exercise caution as Abilify may lower the seizure threshold.
• Diabetes: People with diabetes need to be vigilant, as there is an increased risk of hyperglycaemia, requiring regular monitoring of blood glucose levels.
• The elderly: Particularly individuals with dementia-related psychosis, as their risk of experiencing adverse effects and possibly increased mortality is heightened.

Pregnant or breastfeeding women are advised to avoid this medication unless the potential benefits clearly outweigh the risks. Careful assessment by a healthcare professional is critical for these groups.

Activities to limit

Side effects like dizziness, sedation and altered cognitive function can affect a person's ability to perform everyday tasks such as driving or working in safety-sensitive roles. Consider the following precautions:

• Driving: Patients are warned about the potential for dizziness or light-headedness. Assess how the medication affects alertness before driving.
• Safety-sensitive jobs: Those working in positions requiring high concentration or the operation of machinery should be especially cautious. The risk of sedation or decreased motor control could jeopardise safety.
• Alcohol consumption: Mixing alcohol with Abilify can amplify the risk of sedation and cognitive impairment. It is wise to limit alcohol or avoid it altogether.

If symptoms hinder daily activities, the treatment plan may need to be re-evaluated with a healthcare provider, which can lead to adjustments in dosage or a switch to another medication.

Dosage and adjustments

General regimen (NHS guidance)

When initiating therapy with Abilify (aripiprazole), follow the dose set by the prescriber. Different conditions require different doses:

• Schizophrenia: The common starting dose is 10–15 mg per day, adjusted based on patient response.
• Bipolar I disorder (manic episodes): An initial dose of 15 mg once daily is standard, with possible adjustments based on clinical response.

Adjustments are typically made after a number of weeks based on the individual’s response and side effects. Continuous monitoring is essential to identify the most effective and safest dose for each patient.

Special cases (elderly, comorbidities)

Dosage considerations become particularly important for the elderly or patients with complex comorbidities. For older individuals, initiating treatment often starts at a lower dose due to an increased risk of side effects:

• A lower initial dose is a common approach, especially if there is potential cognitive impairment.
• Those with liver impairment merit cautious dosing. Though the standard adjustment for mild to moderate impairment may not be necessary, those with severe hepatic issues should be closely monitored.
• For patients with significant cardiac or metabolic conditions, including diabetes, a tailored approach is essential, ensuring safety from side effects such as hyperglycaemia and arrhythmias.
• Regular assessments are needed to adjust the regimen as necessary.